ReP USP - Resultado da busca

Artigo de periodico
Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification (2018)
Teles, Andre Lacerda Braga; Silva, Roseane R; Ko, Michelle; Ferreira, Glaucio Monteiro; Pita, Samuel da Rocha; Trossini, Gustavo Henrique Goulart ; Carvalho, Paulo; Castilho, Marcelo Santos
Fonte: Current Topics in Medicinal Chemistry. Unidade: FCF
Assuntos: MODELAGEM MOLECULAR, SCHISTOSOMA MANSONI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Andre Lacerda Braga et al. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, v. 18, p. 406-417, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509150134. Acesso em: 11 nov. 2024.
APA
Teles, A. L. B., Silva, R. R., Ko, M., Ferreira, G. M., Pita, S. da R., Trossini, G. H. G., et al. (2018). Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, 18, 406-417. doi:10.2174/1568026618666180509150134
NLM
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Vancouver
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Artigo de periodico
The anti-inflammatory and immunomodulatory potential of braylin: pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches (2017)
Santo, Renan Fernandes Espirito; Meira, Cássio Santana; Costa, Rafael dos Santos; Souza Filho, Otávio Passos; Evangelista, Afranio Ferreira; Trossini, Gustavo Henrique Goulart ; Ferreira, Glaucio Monteiro; Velozo, Eudes da Silva; Villarreal, Cristiane Flora; Soares, Milena Botelho Pereira
Fonte: PLOS ONE. Unidade: FCF
Assuntos: ADJUVANTES IMUNOLÓGICOS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTO, Renan Fernandes Espirito et al. The anti-inflammatory and immunomodulatory potential of braylin: pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches. PLOS ONE, v. 12, n. 6, p. 1-20 art e0179174, 2017Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0179174. Acesso em: 11 nov. 2024.
APA
Santo, R. F. E., Meira, C. S., Costa, R. dos S., Souza Filho, O. P., Evangelista, A. F., Trossini, G. H. G., et al. (2017). The anti-inflammatory and immunomodulatory potential of braylin: pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches. PLOS ONE, 12( 6), 1-20 art e0179174. doi:10.1371/journal.pone.0179174
NLM
Santo RFE, Meira CS, Costa R dos S, Souza Filho OP, Evangelista AF, Trossini GHG, Ferreira GM, Velozo E da S, Villarreal CF, Soares MBP. The anti-inflammatory and immunomodulatory potential of braylin: pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches [Internet]. PLOS ONE. 2017 ; 12( 6): 1-20 art e0179174.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1371/journal.pone.0179174
Vancouver
Santo RFE, Meira CS, Costa R dos S, Souza Filho OP, Evangelista AF, Trossini GHG, Ferreira GM, Velozo E da S, Villarreal CF, Soares MBP. The anti-inflammatory and immunomodulatory potential of braylin: pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches [Internet]. PLOS ONE. 2017 ; 12( 6): 1-20 art e0179174.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1371/journal.pone.0179174
Artigo de periodico
An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors (2017)
Leite, Franco Henrique Andrade; Froes, Thamires Quadros; Silva, Suellen Goncalves da; Souza, Evandro Italo Macedo de; Fujii, Drielli Gomes Vital; Trossini, Gustavo Henrique Goulart ; Pita, Samuel Silva da Rocha; Castilho, Marcelo Santos
Fonte: European Journal of Medicinal Chemistry. Unidade: FCF
Assuntos: PLANEJAMENTO DE FÁRMACOS, LEISHMANIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Franco Henrique Andrade et al. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. European Journal of Medicinal Chemistry, v. 132, p. 322-332, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.03.043. Acesso em: 11 nov. 2024.
APA
Leite, F. H. A., Froes, T. Q., Silva, S. G. da, Souza, E. I. M. de, Fujii, D. G. V., Trossini, G. H. G., et al. (2017). An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. European Journal of Medicinal Chemistry, 132, 322-332. doi:10.1016/j.ejmech.2017.03.043
NLM
Leite FHA, Froes TQ, Silva SG da, Souza EIM de, Fujii DGV, Trossini GHG, Pita SS da R, Castilho MS. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors [Internet]. European Journal of Medicinal Chemistry. 2017 ; 132 322-332.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ejmech.2017.03.043
Vancouver
Leite FHA, Froes TQ, Silva SG da, Souza EIM de, Fujii DGV, Trossini GHG, Pita SS da R, Castilho MS. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors [Internet]. European Journal of Medicinal Chemistry. 2017 ; 132 322-332.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ejmech.2017.03.043

Unidades USP

ReP

Filtros

Autores

Assuntos

Afiliação dos autores externos não normalizada